Regulation of Nek6 Functions by Its SUMOylation on the $K^{252}$ Residue

  • Lee, Eun-Jeoung (School of Science Education, Chungbuk National University) ;
  • Hyun, Sung-Hee (Department of Pre-medicine, Eulji University School of Medicine) ;
  • Chun, Jae-Sun (Department of Biology Education, Korea National University of Education) ;
  • Shin, Sung-Hwa (School of Science Education, Chungbuk National University) ;
  • Lee, Kyung-Eun (School of Science Education, Chungbuk National University) ;
  • Park, In-Suk (School of Science Education, Chungbuk National University) ;
  • Kang, Sang-Sun (School of Science Education, Chungbuk National University)
  • 발행 : 2007.12.31

초록

Nek6 belongs to NIMA1 (never in mitosis, gene A) related kinase, which was originally identified in Aspergillus nidulans as a serine/threonine kinase critical for cell cycle progression. We noticed that the putative SUMOylation site is localized on the $K^{252}$ residue in $^{251}FKsD^{254}$ of Nek6, based on the consensus sequence ${\Phi}KxE$; where ${\Phi}$ represents L, I, V or F and x is any amino acid. We observed that the Nek6 SUMO mutant (K252R) has decreased protein kinase activity, nuclear speckle localization and protein stability, compared with that of the Nek6 wild type. However, the Nek6 SUMO mutant increased the cell survival rate of COS-1 cells as determined by FACS analysis. Therefore, our data suggest that SUMOylation on the $K^{252}$ residue of Nek6 is required for its normal functions, such as proper nuclear localization, kinase activity and protein stability, to control cell cycle.

키워드

참고문헌

  1. Belham C, Comb MJ and Avruch J (2001) Identification of the NIMA family kinases NEK6/7 as regulators of the p70 ribosomal S6 kinase. Curr BioI 11: 1155-1167 https://doi.org/10.1016/S0960-9822(01)00369-4
  2. Belham C, Roig J, Caldwell JA, Aoyama Y, Kemp BE, Comb M and Avruch J (2003) A mitotic cascade of NIMA family kinases. NercclINek9 activates the Nek6 and Nek7 kinases. J BioI Chem 278: 34897-34909 https://doi.org/10.1074/jbc.M303663200
  3. Bischof O, Schwamborn K, Martin N, Werner A, Sustmann C, Grosschedl R and Dejean A (2006) The E3 SUMO ligase PIASy is a regulator of cellular senescence and apoptosis. Mol Cell 22: 783-794 https://doi.org/10.1016/j.molcel.2006.05.016
  4. Boggio R, Colombo R, Hay RT, Draetta GF and Chiocca S (2004) A mechanism for inhibiting the SUMO pathway. Mol Cell 16: 549-561 https://doi.org/10.1016/j.molcel.2004.11.007
  5. Bohren KM, Nadkami V, Song JR, Gabbay KH and Owerbach D (2004) A M55V polymorphism in a novel SUMO gene (SUMO-4) differentially activates heat shock transcription factors and is associated with susceptibility to type I diabetes mellitus. J BioI Chem 279: 27233-27238 https://doi.org/10.1074/jbc.M402273200
  6. Dorval V and Fraser PE (2006) Small ubiquitin-like modifier (SUMO) modification ofnatlvely unfolded proteins Tau and alpha-synuclein. J BioI Chem 281: 9919-9924 https://doi.org/10.1074/jbc.M510127200
  7. Duprez E, Saurin AJ, Desterro JM, Lallemand-Breitenbach V, Howe K, Boddy MN, Solomon E, de The H, Hay RT and Freemont PS (1999) SUMO-l modification of the acute promyelocytic leukemia protein PML: implications for nuclear localization. J Cell Sci 112: 381-393
  8. Gill G (2004) SUMO and ubiquitin in the nucleus: different fimctions, similar mechanisms?. Genes Dev 18: 2046-2059 https://doi.org/10.1101/gad.1214604
  9. Hashimoto Y, Akita H, Hibino M, Kohri K and Nakanishi M (2002) Identification and characterization of Nek6 protein kinase, a potential human homolog of NIMA histone H3 kinase. Biochem Biophys Res Commun 293: 753-758 https://doi.org/10.1016/S0006-291X(02)00297-8
  10. Hietakangas V, Anckar J, Blomster HA, Fujimoto M, Palvimo JJ, Nakai A and Sistonen L (2006) PDSM, a motif for SUMOylation-dependent SUMO modification. Proc Natl Acad Sci USA 103: 45-50
  11. Kagey MH, Melhuish TA and Wotton D (2003) The polycomb protein Pc2 is a SUMO E3. Cell 113: 127-137 https://doi.org/10.1016/S0092-8674(03)00159-4
  12. Kandli M, Feige E, Chen A, Kilfm G and Motro B (2000) Isolation and characterization of two evolutionarily conserved murine kinases (Nek6 and nek7) related to the fungal mitotic regulator, NIMA. Genomics 68: 187-196 https://doi.org/10.1006/geno.2000.6293
  13. Kikuchi A, Kishida S and Yamamoto H (2006) Regulation of Wnt signaling by protein-protein interaction and post-translational modifications. Exp Mol Med 38: 1-10 https://doi.org/10.1038/emm.2006.1
  14. Lizcano JM, Deak M, Morrice N, Kieloch A, Hastie CJ, Dong L, Schutkowski M, Reimer U and Alessi DR (2002) Molecular basis for the substrate specificity of NIMA-related kinase-6 (NEK6). Evidence that NEK6 does not phosphorylate the hydrophobic motif of ribosomal S6 protein kinase and serum-and glucocorticoid-induced protein kinase in vivo. J BioI Chem 277: 27839-27849 https://doi.org/10.1074/jbc.M202042200
  15. Malumbres M and Barbacid M (2007) Cell cycle kinases in cancer. Curr Opin Genet Dev 17: 60-65 https://doi.org/10.1016/j.gde.2006.12.008
  16. Melchior F and Hengst L (2002) SUMO-1 and p53. Cell Cycle 1: 245-249
  17. Minoguchi S, Minoguchi M and Yoshimura A (2003) Differential control of the NIMA-related kinases, Nek6 and Nek7, by serum stimulation. Biochem Biophys Res Cornrnun 301: 899-906 https://doi.org/10.1016/S0006-291X(03)00049-4
  18. Pichler A, Gast A, Seeler JS, Dejean A and Melchior F (2002) The nucleoporin RanBP2 has SUMO1 E3 ligase activity. Cell 108: 109-120 https://doi.org/10.1016/S0092-8674(01)00633-X
  19. Quannby LM and Mahjoub MR (2005) Caught Nek-ing: cilia and centrioles. J Cell Sci 118: 5161-5169 https://doi.org/10.1242/jcs.02681
  20. Roig J, Mikhailov A, Belham C, and Avruch J (2002) Nerccl, a mammalian NIMA-family kinase, binds the Ran GTPase and regulates mitotic progression. Genes Dev 16: 1640-1658 https://doi.org/10.1101/gad.972202
  21. Sampson DA, Wang M and Matunis MJ (2001) The small ubiquitin-like modifier-1 (SUMO-1) consensus sequence mediates Ubc9 binding and is essential for SUMO-1 modification. J BioI Chem 276: 23164-23169
  22. van Waardenburg RC, Duda DM, Lancaster CS, Schulman BA and Bjornsti MA (2006) Distinct functional domains of Ubc9 dictate cell survival and resistance to genotoxic stress. Mol Cell BioI 26: 4958-4969 https://doi.org/10.1128/MCB.00160-06
  23. Vega FM, Sevilla A and Lazo PA (2004) p53 Stabilization and Accumulation Induced by Human Vaccinia-Related Kinase 1. Mol Cell BioI 24: 10366-10380 https://doi.org/10.1128/MCB.24.23.10366-10380.2004
  24. Wilson VG and Rangasamy D (2001) Intracellular targeting of proteins by sumoylation. Exp Cell Res 271: 57-65 https://doi.org/10.1006/excr.2001.5366
  25. Yang SH, Galanis A, Witty J and Sharrocks AD (2006) An extended consensus motif enhances the specificity of substrate modification by SUMO. EMBO J 25: 5083-5093 https://doi.org/10.1038/sj.emboj.7601383
  26. Yin MJ, Shao L, Voehringer D, Smeal T and Jallal B (2003) The serine/threonine kinase Nek6 is required for cell cycle progression through mitosis. J BioI Chem 278: 52454-52460 https://doi.org/10.1074/jbc.M308080200
  27. Zhang H., Saitoh Hand Matunis MJ (2002) Enzymes of the SUMO modification pathway localize to filaments of the nuclear pore complex. Mol Cell BioI 22: 6498-6508 https://doi.org/10.1128/MCB.22.18.6498-6508.2002